# Preoperative Ultra-hypofractionated Radiotherapy Followed by Surgery for Retroperitoneal Sarcoma (FUSION-01)

> **NCT05224934** · NA · RECRUITING · sponsor: **Cancer Institute and Hospital, Chinese Academy of Medical Sciences** · enrollment: 50 (estimated)

## Conditions studied

- Soft Tissue Sarcoma
- Retroperitoneal Sarcoma
- Radiotherapy Side Effect
- Ultra-hypofractionated Radiotherapy
- Stereotactic Ablative Radiotherapy

## Interventions

- **RADIATION:** ultra-hypofractionated radiotherapy

## Key facts

- **NCT ID:** NCT05224934
- **Lead sponsor:** Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-01-01
- **Primary completion:** 2027-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2025-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05224934

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05224934, "Preoperative Ultra-hypofractionated Radiotherapy Followed by Surgery for Retroperitoneal Sarcoma (FUSION-01)". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT05224934. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*